Nanjing Hicin Pharmaceutical Co., Ltd.
SZSE:300584.SZ
24.7 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 46.822 | 95.068 | 115.596 | 103.226 | 150.101 | 100.767 | 74.583 | 24.503 | 44.001 | 29.601 | 38.616 | 29.461 |
| Short Term Investments
| 0 | -16.454 | -2.854 | 10.002 | -14.367 | -11.598 | 121 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 46.822 | 95.068 | 115.596 | 113.228 | 150.101 | 100.767 | 74.583 | 24.503 | 44.001 | 29.601 | 38.616 | 29.461 |
| Net Receivables
| 243.185 | 199.914 | 120.219 | 103.348 | 113.825 | 88.042 | 78.013 | 37.961 | 24.855 | 29.598 | 27.922 | 23.674 |
| Inventory
| 81.455 | 64.132 | 55.161 | 71.578 | 74.053 | 65.398 | 36.063 | 46.15 | 39.503 | 40.986 | 22.09 | 26.399 |
| Other Current Assets
| 5.784 | 19.265 | 10.98 | 5.589 | 5.188 | 28.486 | 126.432 | 2.877 | 0.001 | 0.078 | -2.073 | 2.276 |
| Total Current Assets
| 377.246 | 378.379 | 301.955 | 293.743 | 343.167 | 282.692 | 315.091 | 111.49 | 108.36 | 100.262 | 86.556 | 81.81 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 646.755 | 505.53 | 370.749 | 310.813 | 313.837 | 323.866 | 278.029 | 223.488 | 177.634 | 151.927 | 132.466 | 74.33 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 168.304 | 171.337 | 172.921 | 144.727 | 61.912 | 38.867 | 27.671 | 24.095 | 24.731 | 25.366 | 11.218 | 11.479 |
| Goodwill and Intangible Assets
| 168.304 | 171.337 | 172.921 | 144.727 | 61.912 | 38.867 | 27.671 | 24.095 | 24.731 | 25.366 | 11.218 | 11.479 |
| Long Term Investments
| 146.791 | 207.154 | 440.433 | 119.943 | 144.312 | 141.876 | 0.8 | 0 | -0 | 0 | 0 | 0 |
| Tax Assets
| 31.869 | 16.602 | 11.761 | 8.377 | 5.754 | 5.207 | 6.156 | 4.848 | 4.604 | 5.496 | 2.214 | 2.031 |
| Other Non-Current Assets
| 47.932 | 14.943 | 4.189 | 28.917 | 0.194 | 1.681 | 4.553 | 6.856 | 7.299 | 10.732 | 8.968 | 21.024 |
| Total Non-Current Assets
| 1,041.651 | 915.567 | 1,000.053 | 612.776 | 526.009 | 511.497 | 317.208 | 259.286 | 214.268 | 193.521 | 154.866 | 108.865 |
| Total Assets
| 1,418.897 | 1,293.945 | 1,302.008 | 906.519 | 869.176 | 794.189 | 632.299 | 370.776 | 322.628 | 293.782 | 241.422 | 190.674 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 35.506 | 59.895 | 80.262 | 20.686 | 34.613 | 45.623 | 25.035 | 26.006 | 16.119 | 23.152 | 26.261 | 18.827 |
| Short Term Debt
| 299.44 | 178.153 | 180.275 | 130.816 | 124.171 | 75.5 | 42.6 | 32.4 | 37.7 | 39.7 | 22 | 18 |
| Tax Payables
| 5.377 | 25.87 | 13.005 | 10.353 | 16.805 | 13.095 | 13.922 | 7.881 | 7.235 | 5.916 | 7.219 | 3.287 |
| Deferred Revenue
| 3.358 | 71.79 | 36.251 | 22.67 | 25.24 | 21.011 | 21.866 | 13.396 | 12.78 | 12.668 | 10.612 | 5.188 |
| Other Current Liabilities
| 61.964 | 7.208 | 4.637 | 6.801 | 21.611 | 17.479 | 15.504 | 13.25 | 11.342 | 7.504 | 6.005 | 4.902 |
| Total Current Liabilities
| 400.268 | 317.046 | 301.425 | 180.973 | 205.635 | 159.613 | 105.005 | 85.053 | 77.941 | 83.024 | 64.878 | 46.918 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0 | 0 | 0 | 39.375 | 0 | 44 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 6.48 | 8.479 | 10.639 | 7.199 | 9.559 | 9.65 | 9.61 | 9.61 | 9.61 | 10.61 | 10.61 | 11.11 |
| Deferred Tax Liabilities Non-Current
| 24.653 | 17.854 | 41.466 | -7.199 | 0 | -44 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| -6.48 | 0 | 0 | 7.199 | 0 | 44 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 24.653 | 26.333 | 52.105 | 46.574 | 9.559 | 53.65 | 9.61 | 9.61 | 9.61 | 10.61 | 10.61 | 11.11 |
| Total Liabilities
| 424.921 | 343.379 | 353.53 | 227.547 | 215.194 | 213.262 | 114.615 | 94.663 | 87.551 | 93.634 | 75.488 | 58.028 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 120 | 120 | 120 | 120 | 120 | 120 | 80 | 60 | 60 | 60 | 60 | 33.824 |
| Retained Earnings
| 596.489 | 560.174 | 557.725 | 300.737 | 281.872 | 217.622 | 162.869 | 127.914 | 91.489 | 60.707 | 29.959 | 35.947 |
| Accumulated Other Comprehensive Income/Loss
| 60.721 | 60.107 | 60.143 | 46.578 | 39.758 | 30.852 | 22.356 | 15.552 | 10.941 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 210.286 | 210.286 | 212.46 | 212.46 | 212.453 | 212.453 | 252.46 | 72.647 | 72.647 | 79.442 | 75.975 | 62.876 |
| Total Shareholders Equity
| 987.496 | 950.566 | 950.327 | 679.775 | 654.082 | 580.926 | 517.684 | 276.114 | 235.077 | 200.148 | 165.934 | 132.647 |
| Total Equity
| 987.496 | 950.566 | 948.478 | 678.972 | 653.983 | 580.926 | 517.684 | 276.114 | 235.077 | 200.148 | 165.934 | 132.647 |
| Total Liabilities & Shareholders Equity
| 1,418.897 | 1,293.945 | 1,302.008 | 906.519 | 869.176 | 794.189 | 632.299 | 370.776 | 322.628 | 293.782 | 241.422 | 190.674 |